Grifols (GIFLF) Cash & Equivalents Growth (5y) (2015 - 2025)

Grifols (GIFLF) Cash & Equivalents Growth (5y) (2015 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 5.96%
Dec 31, 2024 -1.76%
Dec 31, 2023 -13.57%
Dec 31, 2022 -11.71%
Dec 31, 2021 25.94%
Dec 31, 2020 -11.21%
Sep 30, 2020 4.00%
Mar 31, 2020 -16.48%
Dec 31, 2019 -3.23%
Dec 31, 2018 4.11%
Sep 30, 2018 0.91%
Jun 30, 2018 4.98%
Mar 31, 2018 -47.46%
Dec 31, 2017 11.20%
Jun 30, 2017 15.33%
Mar 31, 2017 -76.45%
Dec 31, 2016 16.05%
Sep 30, 2016 34.30%
Jun 30, 2016 1.66%
Mar 31, 2016 35.22%